These ROS not only directly kill cancer cells and pancreatic stellate cells (PSCs) but also downregulate the TGF-β signaling pathway, reducing cancer cell proliferation and drug resistance.76 Additionally, researchers have developed tumor stroma-targeted nitric oxide (NO) nanogels for the co-delivery of NO and TRAIL. The gene discussed is TGFB1; the disease is cancer.